Cleared Traditional

K110688 - MYLABGOLD

K110688 is an FDA 510(k) clearance for MYLABGOLD, manufactured by Esaote. The device is a Class 2 Radiology device with product code IYO cleared through the Traditional 510(k) pathway after a 83-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2011
Decision
83d
Days
Class 2
Risk

K110688 is an FDA 510(k) clearance for the MYLABGOLD. Classified as System, Imaging, Pulsed Echo, Ultrasonic (product code IYO), Class II - Special Controls.

Submitted by Esaote (Carmel, US). The FDA issued a Cleared decision on June 2, 2011 after a review of 83 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1560 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Esaote devices

FDA 510(k) Submission Details - K110688

510(k) Number K110688 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 11, 2011
Decision Date June 02, 2011
Days to Decision 83 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
24d faster than avg
Panel avg: 107d · This submission: 83d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

IYO Device Classification - Class 2, Special Controls

Product Code IYO System, Imaging, Pulsed Echo, Ultrasonic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1560
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - IYO System, Imaging, Pulsed Echo, Ultrasonic

All 516
Devices cleared under the same product code (IYO) and FDA review panel - the closest regulatory comparables to K110688.
DUS-3000/DUS-3000PLUS DIGITAL ULTRASONIC DIAGNOSTIC IMAGING SYSTEM
K112022 · Advanced Instrumentations, Inc. · Sep 2011
VOLCANO S5IINTRAVASCULAR IMAGING AND PRESSURE SYSTEM
K111706 · Volcano Corporation · Jul 2011
DP-50 DIGITAL ULTRASONIC DIAGNOSTIC IMAGING SYSTEM
K111435 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Jul 2011
M5 DIAGNOSTIC ULTRASOUND SYSTEM
K102991 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Oct 2010
A6 PORTABLE ULTRASONIC DIAGNOSTIC SYSTEM
K101337 · Sonoscape Company Limited · Sep 2010
HI VISION PREIRUS DOAGNOSTIC ULTRASOUND SCANNER MODEL HI VISION PREIRUS
K093466 · Hitachi Medical Systems America, Inc. · Jun 2010